Le Lézard
Classified in: Health
Subjects: LGB, CFG, DEI

Government of Canada announces over $7 million to help address harms related to substance use in Ontario


Improving health outcomes for people at risk of substance-related harms and overdose in Ontario

TORONTO, March 14, 2023 /CNW/ - Every day, families and communities across Ontario lose loved ones to overdoses from the increasingly toxic illegal drug supply. Collectively, through harm reduction and treatment services, as well as prevention efforts alongside all levels of government, the Government of Canada is working in tandem to try to reduce stigma, save lives, and ensure all people who use drugs have the life-saving substance use services and supports they need.

Today, the Honourable Carolyn Bennett, Minister of Mental Health and Addictions and Associate Minister of Health, announced over $7 million in federal funding for 8 projects in Ontario through Health Canada's Substance Use and Addictions Program (SUAP). The funding announced today will allow Ontarians to access greater prevention, harm reduction and treatment services including access to safer supply programs. This includes people disproportionately affected by problematic substance use or who face barriers accessing services such as youth, equity-deserving, and 2SLGBTQIA+ individuals.

Today's investment builds on the historic announcement the Government of Canada made in February of $198.6 billion over 10 years to improve health care services for Canadians, reduce surgical backlogs, support health workers, and improve integrated mental health and substance use services. We will continue to work with all levels of government, partners, Indigenous communities, stakeholders, people with lived and living experience of addiction, and organizations across the country to improve health outcomes for all Canadians, save lives, and work towards an end to this national public health crisis.

Quotes

"Every day in Ontario and across Canada, family members, friends, colleagues, and neighbors from all walks of life endure the unspeakable loss of losing a loved one to overdose. We are committed to working with community-based organizations in addressing the increasingly toxic illegal drug supply and overdose crisis. Today's funding will help people in accessing the life-saving substance use resources they need. I thank all the organizations receiving funding for their life-saving work and dedication to reducing stigma."

The Honourable Carolyn Bennett
Minister of Mental Health and Addictions and Associate Minister of Health

"Drug poisoning is one of the most pressing public health crises facing Canada today, causing record numbers of preventable overdoses and deaths, and a strain on our social services and hospital emergency departments. In addition to policy changes to provide safer alternatives to the illicit drug supply, we need to equip people who use drugs and their service providers with information and tools to prevent and respond to overdose, and to promote overall health. With this support from the Government of Canada, we will be able to consolidate the latest evidence and best practices from frontline experience and research and help put this knowledge into action to save lives and promote health."

Jody Jollimore
Executive Director of CATIE, Canada's source for HIV and hepatitis C information

Quick Facts

Related Products

Associated Links

SOURCE Health Canada


These press releases may also interest you

at 02:10
Takeda (TOKYO:4502/NYSE:TAK) today announced financial results for fiscal year 2023 (period ended March 31, 2024), delivering its Management Guidance for Core Operating Profit and exceeding its Management Guidance for Revenue and Core EPS performance...

8 mai 2024
Tri-Tech Forensics, Inc. (Tri-Tech), a leading provider of tactical emergency medical solutions and human identification kits, is pleased to announce the acquisition of SAM® Medical (SAM Medical), a globally renowned provider of innovative medical...

8 mai 2024
The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.64 billion (USD 10.8 million1) in four projects for the development of new drugs for malaria and neglected tropical diseases (NTDs).2  The...

8 mai 2024
Renova Therapeutics, a biotechnology company developing gene therapy-based treatments for cardiovascular and metabolic diseases, announced today that it has focused its development and commercialization efforts for its RT-100 and RT-200 gene...

8 mai 2024
Organovo Holdings, Inc. ("Organovo" or the "Company"), a clinical stage biotechnology company focused on developing novel treatment approaches based on demonstration of clinical promise in three-dimensional (3D) human tissues, today announced the...

8 mai 2024
Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology...



News published on and distributed by: